Wired Next Fest: the third (all digital) edition of Wired Health
The Wired Next Fest, the largest free participation event in Italy dedicated to innovation, changes its skin, transforming itself into an online and on-site festival lasting 4 months, from June 4th to October 11th.
The Festival opens its digital programming with the third edition of Wired Health, which will be held on June 4th and 5th. The two days, in addition to focusing on the current global health emergency linked to the pandemic of COVID-19, will aim to tell the most recent and relevant innovations and trends in digital healthcare, and the opportunities that lie at the intersection of medicine, technology and new lifestyles.
An initiative aimed at managers, public administrators, scientists and researchers, professionals, policy makers and end users who aim to be updated on how and how much digital is transforming the health sector, from its business models to new research and products, therefore to the choices of patients, managers, doctors, citizens.
Numerous national and international experts and opinion leaders will take turns during the two days:
Stella Kyriakides, European Commissioner for Food Health and Safety; Alberto Mantovani, doctor and immunologist, the most quoted Italian scientist in the world, emeritus professor at Humanitas University and scientific director of the IRCCS Humanitas Clinical Institute, who recently published “The inner fire: The immune system and the origin of diseases” (Mondadori, 2020); Ralf Kuhlen, Chief Medical Officer of Helios Health, one of the major hospital and outpatient treatment centers in Europe with 110 hospitals distributed throughout Germany and a strong presence also in Spain and Latin America; Wojciech Wiewiórowski, European Data Protection Supervisor (EDPS); Stefano Bini, Chief Technology Officer of the Department of Orthopedic Surgery of the University of California (UCSF), member of the Advisory Board of the UCSF Health Hub, president of the Digital Orthopedics Conference and professor of Orthopedic Clinic of the University of California; Dimitra Dimitrakopoulou, Visiting Assistant Professor and Marie Curie Global Fellow of the MIT Media Lab of Boston and of the University of Zurich, where he deals with disinformation related to Covid-19; Massimo Galli, infectious disease specialist, professor of Infectious Diseases at the Milan State University and director of the infectious diseases department of the Milanese Luigi Sacco Hospital; Walter Ricciardi, professor of Hygiene and Public Health at the Catholic University of the Sacred Heart of Milan, scientific advisor of the Ministry of Health, member of the Executive Committee of the World Health Organization, president of the World Federation of Public Health Associations (WFPHA) and president of the Mission Board for Cancer of the European Union; Ilaria Capua, virologist and director of the One Health Center of Excellence of the University of Florida; Noemi Bitterman, founder and director of the Masters in Industrial Design focused on the medical design of the Technion-Israel Institute of Technology, which will address the issue of smart hospitals and design at the service of prevention and management of emergencies, from monitoring and intervention devices to healthcare facilities portable; Päivi Kerkola, CEO of Pfizer Italia; Nino Cartabellotta, physician and president of the GIMBE Foundation, which since 1996 has promoted the integration of the best scientific evidence into all political, managerial and professional decisions concerning people’s health; Assaf Shapira, scientist and Lab Manager of the Laboratory for Tissue Engineering and Regenerative Medicine of the University of Tel Aviv, where the world’s first vascularized heart was engineered and 3D printed, using the cells and biological materials of a human being; Giuseppe Testa, director of the Neurogenomics Center of the Human Technopole in Milan and director of the Stem Cell Epigenetics Laboratory of the European Institute of Oncology; Claudia Molteni, Marketing & Customer Innovation Manager of Roche; Matteo Della Porta, professor of Hematology at Humanitas University and head of the Leukemia and Myelodysplasie section, at Humanitas Research Hospital, with him he will discuss the issue of using artificial intelligence for the diagnosis and treatment of leukemias; Alessandro Vespignani, computer physicist, one of the greatest experts in computational epidemiology, is the director of the “Laboratory for the modeling of biological and Socio-technical Systems” of the Northeastern University of Boston; Pierluigi Paracchi, CEO of Genenta Science, a spin-off of the San Raffaele Hospital in Milan that deals with immunotherapy and gene therapy which has so far raised 32.1 million euros in three rounds; Luciano Ravera, managing director of the IRCCS Clinical Institute Humanitas to talk about how to reorganize hospitals so that they are ready to face a new pandemic; Michele Perrino, president and CEO of Medtronic Italia; Roberta Villa, journalist with a degree in medicine and surgery, research fellow for the Ca ‘Foscari University of Venice, where he collaborates on the European QUEST project for the communication of science in Europe, member of the task force of the Council Presidency against disinformation on Covid-19 ; Marta Gaia Zanchi, founder & Managing Partner of Nina Capital, a fund that invests in European entrepreneurs by creating technological solutions for healthcare needs; Eva Runggaldier, Director of clinical research Janssen Italia; Roberto Ascione, CEO of Healthware International, entrepreneur and international opinion leader in the application of digital technologies to health, is very active in the ecosystem of start-ups in digital health, covering various roles of advisors in Europe and the USA; Eugene Borukhovich, Founding Board Member, YourCoach.Health, point of reference in the world of Health Coaching, an approach that combines medical-scientific and coaching skills; Federico Protto, CEO of Retelit; David Vannozzi, director of the CINECA Interuniversity Consortium, which is developing a system to simulate the behavior of proteins that allow the SARS-CoV-2 virus to multiply to identify the most effective molecules to stop it; Giacomo Cuttone, nuclear physicist and research manager in Catania of the Southern National Laboratories (LNS) of the National Institute of Nuclear Physics (INFN), where he directs the Anti-Covid Lab for the verification of the functional qualities of fabrics intended for the realization of masks and other PPE for the prevention of contagion in the COVID-19 emergency; Nicoletta Luppi, President and CEO of MSD Italia. Ilaria Prato, Associate Director Public Affairs of Biogen Italia; Andrea Crisanti, professor of Microbiology at the University of Padua who worked on the Venetian strategy to combat Covid-19; Rodolfo Perriccioli, Marketing Manager of Molteni Farmaceutici; Salvatore Giancane, medical toxicologist of the Ser.T of Bologna and professor of the School of specialization in psychiatry; Alfio Lucchini, psychiatrist and member of the FeDerSerD National Bureau; Cristina Le Grazie, Executive Director Medical Affairs of Gilead Sciences; Franca Melfi, professor of the Department of Surgical, Medical, Molecular Pathology and of the Critical Area of the University of Pisa, thoracic surgeon and director of the Multispecialistic Center of Robotic Surgery of the University Hospital of Pisa; Alessandro Gandolfi, an internationally renowned photographer, four-time winner of the National Geographic Best Edit Award, who conducted a photographic investigation on the theme of longevity and the challenge of lengthening life and many others.
All appointments will be transmitted and disseminated on the social channels of Wired Italia (Facebook, Instagram, YouTube, TikTok) and on Next.Wired.it, the Wired portal dedicated to its events.
Wired Health is made possible thanks to the support of some partners.
L’IRCCS Clinical Institute Humanitas It is the first Italian polyclinic certified for quality by Joint Commission International and considered by Harvard University to be one of the four most innovative hospitals in the world. It is the reference point for research on diseases linked to the immune system, from tumors to rheumatoid arthritis. Humanitas University is the international University dedicated to Life Sciences closely integrated with the hospital.
Biogen, a pioneering biotech company in neuroscience, has the largest portfolio of multiple sclerosis drugs in the world, the first therapy for SMA and is at the forefront of research against Alzheimer’s. It provides digital solutions for the patient communities and the scientific community of all its therapeutic areas.
Janssen is the pharmaceutical company of the Johnson & Johnson Group that concentrates its activity in six key therapeutic areas for global health: neuroscience, infectious disease, onco-hematology, immunology, pulmonary hypertension, cardiovascular and metabolic diseases. Implement collaborative strategies in step with the times to contribute to the sustainability of the health system.
L. Molteni & C., founded in 1892, is a leading company in the opioid drug market, always engaged in the research and development of solutions for the treatment of pain and addictions.
MSD is the Italian subsidiary of Merck & Co, a multinational pharmaceutical company founded 129 years ago and a world leader in the health sector. The company provides innovative healthcare solutions through its ethical drugs, vaccines, biological therapies and animal health products, the result of heavy investments in Research & Development activities.
For 170 years, Pfizer researches, manufactures and markets drugs to improve people’s health and well-being. He has always collaborated with institutions, patient associations, medical-scientific societies, universities, start-ups. A Wired Health will talk about what it means to innovate, but always looking at the needs of patients #Breakthroughs that change patients’ live.
Present in Italy for over 120 years, Roche S.p.A. it is a leader in biotechnology and research. He rewrote the history of medicine thanks to innovative drugs in oncology, hematology, neuroscience and rare diseases.
Medtronic is a leading company in medical technologies, innovative services and solutions that improves the lives of two people every second. Its goal is to collaborate with stakeholders from all over the world to contribute synergistically to increase the efficiency of Healthcare Systems.
Retelit, the Italian operator of digital solutions, infrastructures and ICT, facilitates and supports the digital transformation of healthcare professionals with an integrated offer aimed at the world of healthcare which includes technologies, security, platforms and applications.
Gilead Sciences is a biopharmaceutical company based on research and committed to the discovery, development and marketing of innovative drugs for very serious diseases. The therapeutic areas we focus on include HIV / AIDS, liver disease, hematology and oncology, inflammatory and respiratory diseases.
Generali Italy It is the best known insurer in Italy with over 23 billion total premiums and a widespread network of 40 thousand distributors, in addition to online and bancassurance channels. 13 thousand employees, 120 billion of assets under management. Generali Italia is headed by Alleanza Assicurazioni, Das, Genagricola, Genertel and Genertellife, Generali Welion and Generali Jeniot.